JJDC Newsroom

Clicking on any of the links below will take you to a Web site to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every Web site you visit.

J&J News

Click here to access the latest news from our parent company, Johnson & Johnson.


May 23, 2016
Tom Heyman, President, Johnson & Johnson Innovation – JJDC Inc., was named to the Top 25 from the Global Corporate Venturing Powerlist 2016

May 18, 2016
2016 NEVY Awards (New England Venture Capital Association) Presented by J&J Innovation - JJDC

March 16, 2016
Johnson & Johnson Innovation Launches JLINX: A New Company Incubation Model Located at the Janssen Campus in Belgium

November 18, 2015
Top women in medical devices 2015: Renee Ryan

November 2, 2015
IMAGE Overseas Businesswoman of the Year Award: Dr. Jeanne Bolger

June 15, 2015
Read the MedCity News Survey on Corporate Venture Capital in Healthcare

June 15, 2015
Lake Whillans Research of VC Strategics in Life Sciences

Portfolio Company News

Find the latest investment news from our portfolio companies.

January 5, 2017
BlackThorn Therapeutics Secures $14 Million in Series A Extension Financing

December 12, 2016
Accelerator Corporation Announces $7M Series A Investment in ApoGen Biotechnologies to Develop a New Class of Drugs Targeting Resistance to Cancer Therapy

November 10, 2016
ReVision Optics Raises $32 Million to Fund Expansion of U.S. Commercialization of Raindrop® Near Vision Inlay

November 3, 2016
Inivata and N-of-One Partner to Provide Personalized Genomic Interpretation and Clinical Trial Matching for Cancer Patients

October 20, 2016
BlackThorn Therapeutics Launches to Develop Novel, Targeted Treatments for Neurobehavioral Disorders

September 30, 2016
TRACON Pharmaceuticals Announces a Strategic Licensing Collaboration for Two Janssen Oncology Assets and a $5 Million Equity Investment from Johnson & Johnson Innovation – JJDC, Inc.

August 9, 2016
CVRx® Secures $113 Million in New Financing

August 4, 2016
Torax Medical, Inc. Raises $25 Million in Series E Funding and Welcomes New Chief Commercial Officer

June 29, 2016
ReVision Optics Receives FDA Approval for the Raindrop® Near Vision Inlay

May 3, 2016
Merus Announces First Patient Dosed in Phase 1/2 Trial Evaluating Bispecific Antibody Candidate MCLA-117 in Patients

April 6, 2016
Janssen Enters Worldwide Collaboration and License Agreement with TESARO, Inc., for Niraparib in Prostate Cancer

March 23, 2016
Bristol-Myers Squibb to Acquire Padlock Therapeutics, Inc.

March 16, 2016
Johnson & Johnson Innovation Launches JLINX: A New Company Incubation Model Located at the Janssen Campus in Belgium

March 1, 2016
LifeScan Announces Strategic Collaboration with WellDoc Corporation to Advance Mobile Care Solutions for Type 2 Diabetes Patients

February 2, 2016
Medicxi Ventures Launches as an Independent Venture Capital Firm and Announces Closing of a €210m Fund

January 26, 2016
Inivata Completes £31.5 Million ($45M) Series A Fundraising Round

January 11, 2016
Aelix Therapeutics Completes Series A Funding of €11.5M ($12.7 M) for Therapeutic HIV Vaccine

January 11, 2016
CartiHeal Raises $15 Million

January 11, 2016
Accelerator Corporation Launches Lodo Therapeutics with $17 Million Series A

January 11, 2016
V-Wave Ltd. Announces $28M Series B Financing

January 8, 2016
Protagonist Therapeutics Initiates Phase 1 Study with Oral Peptide PTG-100

January 6, 2016
Accelerator's $48M Biotech Project Looks to Spark the NYC Startup Scene

January 6, 2016
Rodin Announces New Equity Financing and R&D Collaboration with Biogen

January 4, 2016
Padlock Therapeutics Creates West Coast Operations Appointing Scientific Co-founder Kerri Mowen, Ph.D.